WB00858_.GIF (1513 bytes)

BioTech Stock Report  


A valuable tool to help investors make the right decisions.

bluedivider.GIF (2293 bytes)

dnalink.gif (1933 bytes)Sample Issue
dnalink2.gif (1290 bytes) Subscribe
dnalink2.gif (2293 bytes) Back Issues
../images/dnalink2.gif (1290 bytes) Philosophy
dnalink2.gif (1290 bytes) About Us
dnalink2.gif (1290 bytes)Contact Us
dnalink2.gif (1290 bytes) Investor Resources
dnalink3.gif (1814 bytes)
          Member Login
current subscribers only




To view a sample issue
biotech.gif (1723 bytes)
Stock Report

If you've been looking for a source for independent and insightful research that speak plain English, look no more.

Each month the Wong's BioTech Stock Report provides a fresh, intuitive, inside look at the science and business of biotech investing. Our report takes you behind the canned quotes from press releases, beyond the momentum-driven stock analysts, and past the hype of mainstream stock-touters. The BioTech Stock Report gets to the core of what makes biotechnology companies tick: Science and Innovation.

The Wong's BioTech Stock Report is the only biotech newsletter that explains recent developments in light of underlying technology. The BioTech Stock Report looks beyond short-term successes and setbacks because we know that in the long run good technology wins the biotech game.

Our report is an “information integrator” specializing in biotechnology stocks. We bring together the mass of medical scientific data that is available and interpret it for you in a sixteen-page report that is published 12 times a year. The report is divided into four key parts.

An industry analysis with detailed rationale explaining the technology, examining new products, evaluating their potential, the markets and the likely impact it has on a company’s future. We usually discuss either a specific industry segment or talk about important industry-wide issues. This section provides useful background information and helps subscribers evaluate breaking news while building a information base.

The current recommendation section provides analysis of up and coming company in the biotechnology sector. Here you will find easy to understand information and exciting new opportunities in the biotechnology sector. We typically look for stocks with the potential to grow.

In our BioPortfolio, we also focus on companies with more than one product in development. Your best bet is a mix of Phase III and Phase II products, rather than one that may be little more than hype. In this section, the companies are broken down by the amount of risk that is in general risk increases as market cap decreases.

Since we are independent and unbiased, the BioTech Stock Report gives the reader the facts!

So why subscribe to Wong's Biotech Stock Report?

  • The biotechnology sector is an exciting, yet complex and risky investment arena and assessing the scientific basis of new technology requires specialized knowledge. The report is a focused and an in depth source of information allowing investor to have the upper hand when it comes to investing in biotechnology stocks.
  • Think of us as your research laboratory on biotechnology stocks. In each issue of our report, we cover a specific topic such as a condition or disease with a discussion of new or current technologies in layman's language.                     
  • Wong's BioTech Stock Report features publicly traded biotechnology, pharmaceutical, supplies, services and medical-related companies. We provide investors with unique insight into an industry where there is significant growth potential, driven by high demand and lucrative profits.  
  • Wong's BioTech Stock Report provides comprehensive analysis, interpretation, news and commentary for the biotechnology, pharmaceuticals and medical and other related industries. It is committed to give you the essential data you need to make intelligent informed investment decisions. We do the dirty work necessary for proper investing in securities that most individual investors don't bother to do either because it is too tedious or because they don't understand how to do it. Using fundamental and technical calculations we find some of the best ideas for long-term investment strategies.

Wong's BioTech Stock Report is geared for those who are serious about investing in biotech stocks. Our research is independent and unbiased. To check out our performance on our BioPortfolio or to subscribe . . .

Let us help you understand how biotechnology works and to help you become a smarter and better informed stock investor in order to reap the financial rewards of investing in biotechnology stocks.  

If you aren't yet a subscriber to Wong's BioTech Stock Report, you can view a sample issue in PDF format. (If you wish to access the PDF files but do not have Acrobat Reader 3.0 or higher installed on your system, you can DOWNLOAD this free software from Adobe Systems.


Top of Page

  Investment Philosophy l Sample Issue l Back Issues l Subscribe l Contact Us l About Us l Investor Resources

WB00786_.GIF (1795 bytes)

j0205578.wmf (4126 bytes)
Wong's BioTech Stock Report
2017 All rights reserved

Last revised: June 22, 2017